MannKind Completes Acquisition of scPharmaceuticals to Strengthen Cardiometabolic Portfolio and Accelerate Growth

MannKind Corporation (Nasdaq: MNKD) successfully completed the previously announced acquisition of scPharmaceuticals Inc. The acquisition of scPhar...

October 08, 2025 | Wednesday | News
Salipro Biotech Strengthens Japanese IP Portfolio with Two New Patents for Salipro® Membrane Protein Technology

The two new patents expand protection for Salipro Biotech's proprietary technology for stabilizing and extracting challenging membrane proteins, crucial ...

October 08, 2025 | Wednesday | News
Cytiva’s 2025 Global Biopharma Index Reveals Growing Gaps in Industry Resilience Despite Overall Growth

Industry report measures progress in six main areas: supply chain resilience, talent pool, R&D ecosystem, manufacturing agility, government polic...

October 07, 2025 | Tuesday | Reports
Advanz Pharma and Alvotech Secure EMA Acceptance for Xolair® Biosimilar AVT23

Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospita...

October 07, 2025 | Tuesday | News
Leo Cancer Care Partners with TibaRay to Power Next-Gen Upright Radiotherapy with Advanced Linac Technology

Leo Cancer Care announced that it has placed orders for TibaRay's advanced linear accelerators (linacs), which will be evaluated as an upgrade option to th...

October 06, 2025 | Monday | News
Esperion Secures Key Patent Settlement with Dr. Reddy’s, Protecting NEXLETOL and NEXLIZET Until 2040

Esperion announced that it has entered into a settlement agreement with Dr. Reddy’s Laboratories, Inc. and its affiliate Dr. Reddy’s Laborato...

October 06, 2025 | Monday | News
Revvity and Profluent Lead the Next Frontier in Gene Editing with AI-Powered Precision

In conversation with BioPharma BoardRoom, Amanda Haupt, Business Unit Manager for Base Editing at Revvity, shares insights into how the com...

October 06, 2025 | Monday | Interaction
Sitryx Therapeutics Receives FDA Clearance to Advance SYX-5219 Into Phase 1b Trial for Atopic Dermatitis

SYX-5219 is a first-in-class oral PKM2 modulator designed to drive sustained disease remission across a range of autoimmune diseases Phase 1b trial to...

October 03, 2025 | Friday | News
Thermo Fisher Joins AstraZeneca BioVentureHub to Accelerate Next-Gen Life Sciences R&D

-The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, announced a new research and development (R&...

October 02, 2025 | Thursday | News
CRYPTICS Study Confirms Efficacy of CLPH-511 Frozen Platelets in Acute Hemorrhage

CRYPTICS study met the primary efficacy endpoint measure, 24-hour chest tube drainage (Difference in LS Means was 142.0 mL; 95.576% confidence interval...

October 02, 2025 | Thursday | News
Kynexis Doses First Patient in Phase 2 Trial of KYN-5356 for Cognitive Impairment Associated with Schizophrenia

Kynexis, a clinical-stage biotechnology company focused on precision therapeutics for brain diseases, announced that the first patient has been dosed in ...

October 01, 2025 | Wednesday | News
VERAXA Biotech and Secarna Pharmaceuticals Form Strategic Alliance to Develop Next-Generation Antibody Oligonucleotide Conjugates

VERAXA Biotech, an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH,...

October 01, 2025 | Wednesday | News
Amneal Pharmaceuticals Submits BLA for Omalizumab Biosimilar to XOLAIR®, Developed with Kashiv BioSciences

Amneal Pharmaceuticals, Inc.announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for a propos...

September 30, 2025 | Tuesday | News
Concept Life Sciences Expands Integrated Drug Discovery Facilities in High Peak

Concept Life Sciences, a leading contract research organisation (CRO) serving the global life sciences and pharma industry, announces the official openin...

September 30, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close